FY26 Peer Reviewed Cancer Clinical Trial Award for Phase 0 to Phase III studies
This award funds clinical trials under the FY26 Peer Reviewed Cancer Research Program (PRCRP) that could significantly improve cancer treatment or management in one of the program’s topic areas. Trials can range from early-stage proof-of-concept (phase 0/first-in-human) to phase III efficacy studies, including drugs, biologics, devices, guidance, or emerging technologies. Applicants must inclu…
Summary: The fiscal year 2026 (FY26) Peer Reviewed Cancer Research Program (PRCRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of cancer within at least one of the FY26 PRCRP Topic …
Funding Source
Awards & funding
Dates
Documents
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers